Skyward Specialty Insurance Group, Inc. (SKWD) Stock Price & Analysis
Skyward Specialty Insurance Group, Inc. (SKWD) closed at USD 62.16 on Thursday, October 22, 2026, up 1.24% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 61.4; the Oct 22, 2026 session ranged USD 61.3–62.47 on volume of 374,710 shares. Market capitalization is $2.76B, with a 52-week range of USD 40.6–65.69 (NMS). Source: Nexqual, retrieved October 23, 2026 at 10:01 UTC.
Also available as compact Markdown for AI agents: nexqual.com/SKWD.md
Key facts (SKWD)
- Last four reported quarters (through Jun 30, 2026): revenue $1.73B, net income $188M (10.8% margin) (SEC filings).
- Valuation: P/E 14.7x (avg 15.1x at the last 3 fiscal year-ends).
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $465K; 2 not under a Rule 10b5-1 plan ($465K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $94K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (13 analysts), mean target USD 70.73 (range 56–80).
- Total return with dividends: 1Y +33.4% vs S&P 500 +14.9%; 5Y +225.4% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD 1.22, revenue estimate $509M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (SKWD)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $550M | $642M | $886M | $1.15B | $1.42B | $1.73B |
| Net income | $38.3M | $39.4M | $86.0M | $119M | $170M | $188M |
| EPS (diluted) | $1.18 | $1.21 | $2.24 | $2.87 | $4.07 | — |
| Free cash flow | $173M | $207M | $335M | $301M | $403M | — |
| Net margin | 7.0% | 6.1% | 9.7% | 10.3% | 12.0% | 10.8% |
| Revenue growth | — | +16.8% | +37.9% | +29.8% | +23.2% | — |
| Cash + short-term investments | $42.1M | $45.4M | $65.9M | $122M | $169M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (SKWD)
P/E 14.7x · P/S 1.6x · P/B 2.2x · Earnings yield 6.81%
P/E at fiscal year-ends: Dec 2025 12.6x, Dec 2024 17.6x, Dec 2023 15.1x.
Insider sales (SEC Form 4, open-market, last ~7 months) (SKWD)
0 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | Schmitt Thomas N | CPO, Skyward Group | 8,397 | $431K | 44.8% | No | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-11 | Ashe Gena L | Director | 740 | $34K | 13.9% | No | Too little history (no open-market trades in 2023 or 2024) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (SKWD)
1 purchase, $94K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-05-21 | Kuczinski Anthony J | Director | 2,000 | $94K | 47.1 | Too little history (no open-market trades in 2025) |
Analysts (SKWD)
Consensus Buy (mean 2.00 on a 1–5 scale), 13 analysts; mean target USD 70.73 (low 56, high 80).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-11 | TD Cowen | Target raised | Hold | $49 → $65 |
| 2026-08-10 | Keefe, Bruyette & Woods | Target raised | Outperform | $72 → $75 |
| 2026-08-06 | Truist Securities | Target raised | Buy | $70 → $75 |
| 2026-08-05 | Barclays | Target raised | Overweight | $65 → $68 |
| 2026-07-15 | Piper Sandler | Target raised | Overweight | $68 → $72 |
| 2026-07-08 | Keefe, Bruyette & Woods | Target raised | Outperform | $65 → $72 |
| 2026-07-07 | Barclays | Target raised | Overweight | $60 → $65 |
| 2026-07-07 | Piper Sandler | Target raised | Overweight | $55 → $68 |
Total return (dividends reinvested) (SKWD)
| 1Y (from 2025-10-23) | 5Y (from 2023-01-09) | |
|---|---|---|
| Total return | +33.4% | +225.4% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +33.5% | +36.6% |
| Volatility (annualized) | 34.3% | 33.5% |
| Max drawdown | -20.8% (Dec 2025→Mar 2026) | -35.1% (May 2025→Mar 2026) |
SKWD revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| SUA commission revenue | $2.8M | 60.6% | -10.1% |
| Other | $1.5M | 31.9% | +268.0% |
| SUA fee income | $342,000 | 7.5% | -43.8% |
| Total revenue | $4.6M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
SKWD suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Apollo Group Holdings | “•Retention of Key Personnel and Customers: The success of the acquisition depends in part on our ability to retain key Apollo employees, partners, and customers.” |
Quoted from the company's 10-K filed Mar 2, 2026.
SKWD analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.22 | $1.20 | +1.8% | $509.3M | 13 |
| Next quarter (ends Dec 2026) | $1.26 | $1.26 | +0.2% | $505.3M | 12 |
| Current fiscal year (ends Dec 2026) | $5.04 | $4.89 | +3.0% | $1.97B | 13 |
| Next fiscal year (ends Dec 2027) | $5.53 | $5.48 | +0.9% | $2.11B | 12 |
Key Statistics (as of October 23, 2026 at 10:01 UTC)
| Price | USD 62.16 |
|---|---|
| Change | ▲ 1.24% (up) |
| Previous Close | USD 61.4 |
| Open | USD 61.47 |
| Day Range | USD 61.3 – 62.47 |
| 52-Week Range | USD 40.6 – 65.69 |
| Volume | 374,710 shares |
| Market Cap | $2.76B |
| Exchange | NMS |
Technical Analysis (SKWD)
Nexqual's technical model rates SKWD "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 10:01 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 68.31 (neutral) |
| vs SMA50 | Above (USD 57.43) |
| MACD | 1.38 (positive) |
Analyst Ratings (SKWD)
Wall Street analysts rate SKWD "Buy" based on 13 analysts, with a mean price target of USD 70.73 (range USD 56–80), per Nexqual as of October 23, 2026 at 10:01 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 13 |
| Mean Target | USD 70.73 |
| High Target | USD 80 |
| Low Target | USD 56 |
| Buy / Hold / Sell | 9 / 4 / 0 |
Earnings (SKWD)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 1.22 |
| Revenue Estimate | $509.30M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.3 vs est 1.17 ▲ beat |
| 2026-03-31 | USD 1.25 vs est 1.11 ▲ beat |
| 2025-12-31 | USD 1.17 vs est 1.02 ▲ beat |
| 2025-09-30 | USD 1.05 vs est 0.89 ▲ beat |
Source: Nexqual, October 23, 2026 at 10:01 UTC.
Financials & Fundamentals (SKWD)
| Total Revenue | $1.73B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +53.00% |
| Gross Margin | +30.46% |
| Operating Margin | +14.78% |
| Profit Margin | +10.84% |
| ROE | +17.34% |
| Debt / Equity | 0.34 |
| Current Ratio | 1.98 |
| Total Cash | $611.85M |
| Total Debt | $437.20M |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | $402.62M (28.4% of revenue) |
Source: Nexqual, October 23, 2026 at 10:01 UTC.
Financial Health Score (SKWD)
Nexqual rates Skyward Specialty Insurance Group, Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 10:01 UTC.
| Growth | Strong — Revenue +23% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 30%, operating 15% (last 12 months) |
| Balance Sheet | Solid — $612M cash vs $437M debt, net cash position |
| Cash Flow | Strong — FCF $403M (FY ended Dec 2025, 10-K), 28% margin |
| Efficiency | Solid — ROE 17%, ROA 3.1% |
Ownership (SKWD)
| Insider Ownership | +8.18% |
|---|---|
| Institutional Ownership | +92.81% |
| Shares Outstanding | 44.40M |
| Float | 40.58M |
| Short % of Float | +4.79% |
Source: Nexqual, October 23, 2026 at 10:01 UTC.
Leadership (SKWD)
Skyward Specialty Insurance Group, Inc. is led by Andrew Scott Robinson, Chairman of the Board & CEO, per Nexqual as of October 23, 2026 at 10:01 UTC.
| Chairman of the Board & CEO | Andrew Scott Robinson |
|---|---|
| Chief Financial Officer | Mark William Haushill |
| President of Reinsurance & Head of Actuarial | Sandip A. Kapadia FCAS, MAAA |
| Executive VP & President of U.S. Property & Casualty | John Ambrose Burkhart |
| Vice President of Investor Relations | Jordan Arnold |
Major Backers & Investors (SKWD)
Notable institutional backers of Skyward Specialty Insurance Group, Inc. include Reinhart Partners, LLC, Price (T.Rowe) Associates Inc, Invesco, according to Nexqual as of October 23, 2026 at 10:01 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Reinhart Partners, LLC | 6.51% |
| Price (T.Rowe) Associates Inc | 5.5% |
| Invesco | 4.59% |
| Ameriprise Financial, Inc. | 3.63% |
| Westwood Holdings Group Inc. | 2.87% |
| American Century Companies Inc | 2.77% |
| Wasatch Advisors LP | 2.73% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.28% |
| Vanguard Group | 3.69% |
| State Street | 2.63% |
Source: Nexqual, October 23, 2026 at 10:01 UTC.
From Skyward Specialty Insurance Group, Inc.'s Latest SEC 10-K Filing (filed 2026-03-02)
Key Strengths & Strategy (as disclosed to the SEC)
- Typically, the program administrators possess a competitive advantage (owing to their scale in a particular market niche and/or proprietary technology) that we believe would be difficult for us to replicate on our own.
- For example, certain of our program administrator partners have developed proprietary technology to optimize risk selection and pricing in specific markets.
- Our approach for managing medical costs, combined with our claims oversight, enables us to partner with select distribution partners.
- All of these factors enable us to respond to market opportunities and dislocations by deploying capital where we believe we can consistently earn attractive risk-adjusted returns.
Partnerships
- We believe the combination of our underwriting and claims expertise with their scale and/or technology creates a more powerful partnership than either party could present to the market on its own.
Legal & Regulatory Risks (Item 1A, quoted)
- We are subject to extensive regulation, which may adversely affect our ability to achieve our business objectives. In addition, if we fail to comply with these regulations, we may be subject to penalties, including fines and suspensions, which may adversely affect our financial condition and results of operations.
- We may become subject to additional government or market regulation, which may have a material adverse impact on our business.
- Our business could be adversely affected by changes in laws, including those relating to asset and reserve valuation requirements, surplus requirements, limitations on investments and dividends, enterprise risk and risk-based capital requirements.
- Changes to the U.S. tax laws and implementation of new tax policies could have a significant negative impact on the overall economy and our business.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HCI | HCI Group, Inc. | USD 206.68 | ▲ 1.11% |
| SLDE | Slide Insurance Holdings, Inc. | USD 27.75 | ▲ 2.36% |
| LMND | Lemonade, Inc. | USD 45.41 | ▲ 0.29% |
| PRCH | Porch Group, Inc. | USD 17.94 | ▼ 3.5% |
| PLMR | Palomar Holdings, Inc. | USD 144.53 | ▲ 3.85% |
| HMN | Horace Mann Educators Corporati | USD 47.37 | ▲ 2.2% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:01 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt